Nuclear Diagnostic Products of Philadelphia Revenue, Growth & Competitor Profile

DBA CHERRY HILL PHARMACY
DBA NUCLEAR DIAGNOSTIC

Company Profile & Annual Report for Nuclear Diagnostic Products of Philadelphia

Access the complete profile.

Nuclear Diagnostic Products of Philadelphia Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	2 Keystone Ave Ste 200 Cherry Hill, NJ 08003

Note: Revenues for privately held companies are statistical evaluations.


Nuclear Diagnostic Products of Philadelphia's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nuclear Diagnostic Products of Philadelphia's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Nuclear Diagnostic Products of Philadelphia is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Nuclear Diagnostic Products of Philadelphia Annual Revenue and Growth Rate

Nuclear Diagnostic Products of Philadelphia	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nuclear Diagnostic Products of Philadelphia's revenues are gauged from an analysis of company filings.

Nuclear Diagnostic Products of Philadelphia's Income Statement (based on Industry Averages)

Nuclear Diagnostic Products of Philadelphia P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Nuclear Diagnostic Products of Philadelphia's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nuclear Diagnostic Products of Philadelphia, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Nuclear Diagnostic Products of Philadelphia. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SIEGFRIED USA	Pennsville, NJ	100
AAA PHARMACEUTICAL	Lumberton, NJ	71
UNITED PHARMA TECHNOLOGIES	South Plainfield, NJ	47
NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA	Cherry Hill, NJ	41
TELIGENT	Voorhees, NJ	26
COPPERHEAD CHEMICAL	Mount Laurel, NJ	24

Future Competition: Nuclear Diagnostic Products of Philadelphia's Fastest Growing Competitors

These companies are in the same general field as Nuclear Diagnostic Products of Philadelphia and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)